Amphastar Pharmaceuticals
AMPH
#5766
Rank
NZ$2.30 B
Marketcap
NZ$53.97
Share price
2.10%
Change (1 day)
17.92%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): NZ$3.03

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$3.16. In 2025 the company made an earnings per share (EPS) of NZ$3.81 a decrease over its 2024 EPS that were of NZ$5.98.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$3.03-20.57%
2025NZ$3.81-36.17%
2024NZ$5.9815.85%
2023NZ$5.1651.87%
2022NZ$3.4043.85%
2021NZ$2.363521.88%
2020NZ$0.06520-96.55%
2019NZ$1.89-900%
2018NZ-$0.24-238.6%
2017NZ$0.17-60.92%
2016NZ$0.44
2014NZ-$0.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
NZ-$23.50-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
NZ-$9.45-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
NZ-$4.25-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
NZ-$7.03-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA